[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Hematopoietic Stem Cells (HSCs) Market Report 2017

October 2017 | 114 pages | ID: U01417AB6AEEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Hematopoietic Stem Cells (HSCs) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Hematopoietic Stem Cells (HSCs) in these regions, from 2012 to 2022 (forecast).
United States Hematopoietic Stem Cells (HSCs) market competition by top manufacturers/players, with Hematopoietic Stem Cells (HSCs) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Kite Pharma Inc.
  • Thermo Fisher Scientific
  • PromoCell
  • CellGenix Technologie Transfer GmbH
  • Cesca Therapeutics Inc.
  • R&D Systems
  • Genlantis
  • Lonza Group Ltd.
  • TiGenix N.V.
  • ScienCell Research Laboratories
  • China Cord Blood Corporation
  • Vcanbio
  • Boyalife
  • Beike Biotechnology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Leukocyte
  • Lymphocytes
  • Red Blood Cells
  • Platelets
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Hematopoietic Stem Cells (HSCs) for each application, including
  • Blood System Diseases
  • Autoimmune Diseases
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Hematopoietic Stem Cells (HSCs) Market Report 2017

1 HEMATOPOIETIC STEM CELLS (HSCS) OVERVIEW

1.1 Product Overview and Scope of Hematopoietic Stem Cells (HSCs)
1.2 Classification of Hematopoietic Stem Cells (HSCs) by Product Category
  1.2.1 United States Hematopoietic Stem Cells (HSCs) Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Hematopoietic Stem Cells (HSCs) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Leukocyte
  1.2.4 Lymphocytes
  1.2.5 Red Blood Cells
  1.2.6 Platelets
1.3 United States Hematopoietic Stem Cells (HSCs) Market by Application/End Users
  1.3.1 United States Hematopoietic Stem Cells (HSCs) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Blood System Diseases
  1.3.3 Autoimmune Diseases
  1.3.4 Other
1.4 United States Hematopoietic Stem Cells (HSCs) Market by Region
  1.4.1 United States Hematopoietic Stem Cells (HSCs) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Hematopoietic Stem Cells (HSCs) Status and Prospect (2012-2022)
  1.4.3 Southwest Hematopoietic Stem Cells (HSCs) Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Hematopoietic Stem Cells (HSCs) Status and Prospect (2012-2022)
  1.4.5 New England Hematopoietic Stem Cells (HSCs) Status and Prospect (2012-2022)
  1.4.6 The South Hematopoietic Stem Cells (HSCs) Status and Prospect (2012-2022)
  1.4.7 The Midwest Hematopoietic Stem Cells (HSCs) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Hematopoietic Stem Cells (HSCs) (2012-2022)
  1.5.1 United States Hematopoietic Stem Cells (HSCs) Sales and Growth Rate (2012-2022)
  1.5.2 United States Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2012-2022)

2 UNITED STATES HEMATOPOIETIC STEM CELLS (HSCS) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Hematopoietic Stem Cells (HSCs) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Hematopoietic Stem Cells (HSCs) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Hematopoietic Stem Cells (HSCs) Average Price by Players/Suppliers (2012-2017)
2.4 United States Hematopoietic Stem Cells (HSCs) Market Competitive Situation and Trends
  2.4.1 United States Hematopoietic Stem Cells (HSCs) Market Concentration Rate
  2.4.2 United States Hematopoietic Stem Cells (HSCs) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hematopoietic Stem Cells (HSCs) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEMATOPOIETIC STEM CELLS (HSCS) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Hematopoietic Stem Cells (HSCs) Sales and Market Share by Region (2012-2017)
3.2 United States Hematopoietic Stem Cells (HSCs) Revenue and Market Share by Region (2012-2017)
3.3 United States Hematopoietic Stem Cells (HSCs) Price by Region (2012-2017)

4 UNITED STATES HEMATOPOIETIC STEM CELLS (HSCS) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Hematopoietic Stem Cells (HSCs) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Hematopoietic Stem Cells (HSCs) Revenue and Market Share by Type (2012-2017)
4.3 United States Hematopoietic Stem Cells (HSCs) Price by Type (2012-2017)
4.4 United States Hematopoietic Stem Cells (HSCs) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HEMATOPOIETIC STEM CELLS (HSCS) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Hematopoietic Stem Cells (HSCs) Sales and Market Share by Application (2012-2017)
5.2 United States Hematopoietic Stem Cells (HSCs) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEMATOPOIETIC STEM CELLS (HSCS) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Kite Pharma Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Thermo Fisher Scientific
  6.2.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 PromoCell
  6.3.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 CellGenix Technologie Transfer GmbH
  6.4.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Cesca Therapeutics Inc.
  6.5.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 R&D Systems
  6.6.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Genlantis
  6.7.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Lonza Group Ltd.
  6.8.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 TiGenix N.V.
  6.9.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 ScienCell Research Laboratories
  6.10.2 Hematopoietic Stem Cells (HSCs) Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 China Cord Blood Corporation
6.12 Vcanbio
6.13 Boyalife
6.14 Beike Biotechnology

7 HEMATOPOIETIC STEM CELLS (HSCS) MANUFACTURING COST ANALYSIS

7.1 Hematopoietic Stem Cells (HSCs) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hematopoietic Stem Cells (HSCs)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hematopoietic Stem Cells (HSCs) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hematopoietic Stem Cells (HSCs) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEMATOPOIETIC STEM CELLS (HSCS) MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Hematopoietic Stem Cells (HSCs) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Hematopoietic Stem Cells (HSCs) Sales Volume Forecast by Type (2017-2022)
11.3 United States Hematopoietic Stem Cells (HSCs) Sales Volume Forecast by Application (2017-2022)
11.4 United States Hematopoietic Stem Cells (HSCs) Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Hematopoietic Stem Cells (HSCs)
Figure United States Hematopoietic Stem Cells (HSCs) Market Size (K Units) by Type (2012-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Volume Market Share by Type (Product Category) in 2016
Figure Leukocyte Product Picture
Figure Lymphocytes Product Picture
Figure Red Blood Cells Product Picture
Figure Platelets Product Picture
Figure United States Hematopoietic Stem Cells (HSCs) Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Hematopoietic Stem Cells (HSCs) by Application in 2016
Figure Blood System Diseases Examples
Table Key Downstream Customer in Blood System Diseases
Figure Autoimmune Diseases Examples
Table Key Downstream Customer in Autoimmune Diseases
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Hematopoietic Stem Cells (HSCs) Market Size (Million USD) by Region (2012-2022)
Figure The West Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Sales (K Units) and Growth Rate (2012-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hematopoietic Stem Cells (HSCs) Sales Share by Players/Suppliers
Figure 2017 United States Hematopoietic Stem Cells (HSCs) Sales Share by Players/Suppliers
Figure United States Hematopoietic Stem Cells (HSCs) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hematopoietic Stem Cells (HSCs) Revenue Share by Players/Suppliers
Figure 2017 United States Hematopoietic Stem Cells (HSCs) Revenue Share by Players/Suppliers
Table United States Market Hematopoietic Stem Cells (HSCs) Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Hematopoietic Stem Cells (HSCs) Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Hematopoietic Stem Cells (HSCs) Market Share of Top 3 Players/Suppliers
Figure United States Hematopoietic Stem Cells (HSCs) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hematopoietic Stem Cells (HSCs) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hematopoietic Stem Cells (HSCs) Product Category
Table United States Hematopoietic Stem Cells (HSCs) Sales (K Units) by Region (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Sales Share by Region (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Share by Region (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Market Share by Region in 2016
Table United States Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Revenue Share by Region (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region in 2016
Table United States Hematopoietic Stem Cells (HSCs) Price (USD/Unit) by Region (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Sales (K Units) by Type (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Sales Share by Type (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Share by Type (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Market Share by Type in 2016
Table United States Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hematopoietic Stem Cells (HSCs) by Type (2012-2017)
Figure Revenue Market Share of Hematopoietic Stem Cells (HSCs) by Type in 2016
Table United States Hematopoietic Stem Cells (HSCs) Price (USD/Unit) by Types (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Growth Rate by Type (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Sales (K Units) by Application (2012-2017)
Table United States Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Market Share by Application in 2016
Table United States Hematopoietic Stem Cells (HSCs) Sales Growth Rate by Application (2012-2017)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Growth Rate by Application (2012-2017)
Table Kite Pharma Inc. Basic Information List
Table Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table PromoCell Basic Information List
Table PromoCell Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure PromoCell Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure PromoCell Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure PromoCell Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table CellGenix Technologie Transfer GmbH Basic Information List
Table CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table Cesca Therapeutics Inc. Basic Information List
Table Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table R&D Systems Basic Information List
Table R&D Systems Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure R&D Systems Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure R&D Systems Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure R&D Systems Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table Genlantis Basic Information List
Table Genlantis Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genlantis Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure Genlantis Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure Genlantis Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table Lonza Group Ltd. Basic Information List
Table Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table TiGenix N.V. Basic Information List
Table TiGenix N.V. Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TiGenix N.V. Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure TiGenix N.V. Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table ScienCell Research Laboratories Basic Information List
Table ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Sales Growth Rate (2012-2017)
Figure ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Sales Market Share in United States (2012-2017)
Figure ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue Market Share in United States (2012-2017)
Table China Cord Blood Corporation Basic Information List
Table Vcanbio Basic Information List
Table Boyalife Basic Information List
Table Beike Biotechnology Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hematopoietic Stem Cells (HSCs)
Figure Manufacturing Process Analysis of Hematopoietic Stem Cells (HSCs)
Figure Hematopoietic Stem Cells (HSCs) Industrial Chain Analysis
Table Raw Materials Sources of Hematopoietic Stem Cells (HSCs) Major Players/Suppliers in 2016
Table Major Buyers of Hematopoietic Stem Cells (HSCs)
Table Distributors/Traders List
Figure United States Hematopoietic Stem Cells (HSCs) Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Hematopoietic Stem Cells (HSCs) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Volume (K Units) Forecast by Type in 2022
Table United States Hematopoietic Stem Cells (HSCs) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Volume (K Units) Forecast by Application in 2022
Table United States Hematopoietic Stem Cells (HSCs) Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Hematopoietic Stem Cells (HSCs) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hematopoietic Stem Cells (HSCs) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories